PET imaging of PARP expression using [18F]olaparib
PARP inhibitors are increasingly being studied as cancer drugs, as single agents or as a part of combination therapies. Imaging of PARP using a radiolabeled inhibitor has been proposed for patient selection, outcome prediction, dose optimization, genotoxic therapy evaluation, and target engagement i...
| Автори: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Journal article |
| Опубліковано: |
Society of Nuclear Medicine
2018
|